Top Qs
Timeline
Chat
Perspective
Adaptimmune
American biopharmaceutical startup From Wikipedia, the free encyclopedia
Remove ads
Adaptimmune is a biopharmaceutical company that develops T cell therapies against cancer. The company was founded in 2008 in the UK with links to both Oxford University and the University of Pennsylvania. It has headquarters in Philadelphia and Milton Park.[1] In August 2024, the US Food and Drug Administration granted accelerated approval to Adaptimmune's Tecelra, a therapy against a rare form of cancer. Tecelra is the first T cell therapy to be approved for use against a solid tumor.[2][3][4][5][6]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads